BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 14674325)

  • 1. [Lung function test for COPD].
    Itabashi S
    Nihon Rinsho; 2003 Dec; 61(12):2150-7. PubMed ID: 14674325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Spirometry and other pulmonary function tests for the screening and evaluation of patients with chronic obstructive pulmonary disease (COPD)].
    Yoshimi K; Seyama K
    Nihon Rinsho; 2007 Apr; 65(4):664-9. PubMed ID: 17419385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Stage and prognosis of COPD].
    Akashiba T
    Nihon Rinsho; 2003 Dec; 61(12):2089-93. PubMed ID: 14674315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
    Kömüs N; Tertemiz KC; Sevinç C
    Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases.
    Majumdar S; Sen S; Mandal SK
    J Indian Med Assoc; 2007 Oct; 105(10):565-6, 568, 570 passim. PubMed ID: 18383952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comments on screening spirometry for detection of COPD].
    van den Berg JW; van der Molen T; Kerstjens HA; Quanjer PH
    Ned Tijdschr Geneeskd; 2007 Jul; 151(28):1557-60. PubMed ID: 17715762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic management of chronic obstructive pulmonary disease.
    Broekhuizen BD; Sachs AP; Hoes AW; Verheij TJ; Moons KG
    Neth J Med; 2012 Jan; 70(1):6-11. PubMed ID: 22271808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Issues in pulmonary function testing for the screening and diagnosis of chronic obstructive pulmonary disease.
    Lam DC; Hui CK; Ip MS
    Curr Opin Pulm Med; 2012 Mar; 18(2):104-11. PubMed ID: 22262139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower limit of normal or FEV1/FVC < 0.70 in diagnosing COPD: an evidence-based review.
    Mohamed Hoesein FA; Zanen P; Lammers JW
    Respir Med; 2011 Jun; 105(6):907-15. PubMed ID: 21295958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spirometry in chronic obstructive lung disease (COPD).
    Karkhanis VS; Joshi JM
    J Assoc Physicians India; 2012 Feb; 60 Suppl():22-6. PubMed ID: 23155809
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnosis of chronic obstructive pulmonary disease earlier than current Global Initiative for Obstructive Lung Disease guidelines using a feasible spirometry parameter (maximal-mid expiratory flow/forced vital capacity).
    Mirsadraee M; Boskabady MH; Attaran D
    Chron Respir Dis; 2013; 10(4):191-6. PubMed ID: 24177680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spirometry for the diagnosis and management of chronic obstructive pulmonary disease.
    Macintyre NR
    Respir Care; 2009 Aug; 54(8):1050-7. PubMed ID: 19650946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung function testing in the elderly--can we still use FEV1/FVC<70% as a criterion of COPD?
    Medbø A; Melbye H
    Respir Med; 2007 Jun; 101(6):1097-105. PubMed ID: 17239575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bronchial obstruction reversibility test in the assessment of COPD severity--controversies].
    Maskey-Warzechowska M; Pankowska M; Chazan R
    Pneumonol Alergol Pol; 2006; 74(1):68-71. PubMed ID: 17175980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving early detection of COPD: the role of spirometry screening assessment.
    Holt K
    Prof Nurse; 2004 Nov; 20(3):31-3. PubMed ID: 15552437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow and volume responses after routine salbutamol reversibility testing in mild to very severe COPD.
    Schermer T; Heijdra Y; Zadel S; van den Bemt L; Boonman-de Winter L; Dekhuijzen R; Smeele I
    Respir Med; 2007 Jun; 101(6):1355-62. PubMed ID: 17098407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does lobectomy for lung cancer in patients with chronic obstructive pulmonary disease affect lung function? A multicenter national study.
    Baldi S; Ruffini E; Harari S; Roviaro GC; Nosotti M; Bellaviti N; Venuta F; Diso D; Rea F; Schiraldi C; Durigato A; Pavanello M; Carretta A; Zannini P
    J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1616-22. PubMed ID: 16308007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a claims-based prediction model for COPD severity.
    Macaulay D; Sun SX; Sorg RA; Yan SY; De G; Wu EQ; Simonelli PF
    Respir Med; 2013 Oct; 107(10):1568-77. PubMed ID: 23806285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of chronic obstructive pulmonary disease severity on surgical outcomes in patients undergoing non-emergent coronary artery bypass grafting.
    Saleh HZ; Mohan K; Shaw M; Al-Rawi O; Elsayed H; Walshaw M; Chalmers JA; Fabri BM
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):108-13; discussion 113. PubMed ID: 22290913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic and treatment of chronic obstructive pulmonary disease based on GOLD statement 2011].
    Barczyk A; Pierzchała W
    Pol Merkur Lekarski; 2012 Oct; 33(196):187-92. PubMed ID: 23272604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.